Compare ANGH & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGH | BNGO |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1M | 24.3M |
| IPO Year | N/A | 2018 |
| Metric | ANGH | BNGO |
|---|---|---|
| Price | $2.35 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 19.7K | ★ 306.6K |
| Earning Date | 04-30-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $96,736,848.00 | $28,720,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $24.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 85.06 | N/A |
| 52 Week Low | $2.25 | $1.06 |
| 52 Week High | $7.60 | $6.32 |
| Indicator | ANGH | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 36.43 | 25.58 |
| Support Level | $2.29 | $1.07 |
| Resistance Level | $2.44 | $1.23 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 7.90 | 5.19 |
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.